ANEW Medical Shares Double After European Patent for Klotho Gene Systems

Dow Jones

2024-06-27

By Chris Wack

Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.

The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.

ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.

In March, the company received patent approval in China, and is now approved in Hong Kong as well.

ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.

Write to Chris Wack at chris.wack@wsj.com

(END) Dow Jones Newswires

June 26, 2024 13:39 ET (17:39 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2446311876"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2446311876\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2446311876?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-27 01:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446311876","market":"nz","top_or_hot":-1,"title":"ANEW Medical Shares Double After European Patent for Klotho Gene Systems","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n</p>\n<p>\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n</p>\n<p>\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n</p>\n<p>\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n</p>\n<p>\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2024 13:39 ET (17:39 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ANEW Medical Shares Double After European Patent for Klotho Gene Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nANEW Medical Shares Double After European Patent for Klotho Gene Systems\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-06-27 01:39</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Chris Wack \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n</p>\n<p>\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n</p>\n<p>\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n</p>\n<p>\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n</p>\n<p>\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Chris Wack at chris.wack@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2024 13:39 ET (17:39 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANEW","symbol_name":"ProShares MSCI Transformational Changes ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2446311876","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446311876","pubTimestamp":1719423540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems.The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona.In March, the company received patent approval in China, and is now approved in Hong Kong as well.ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANEW":"ProShares MSCI Transformational Changes ETF","OTS.SI":"OTS Holdings","BK6509":"食品和饮料股","BK6114":"包装食品与肉类"},"translate_title":"Klotho Gene Systems获得欧洲专利后，ANEW Medical股价翻倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANEW":1,"OTS.SI":1,"WENA":0.9},"content_text":"By Chris Wack \n\n\n \n\n\n  Shares of ANEW Medical doubled, to $3.80, after the company said it has been granted and issued a patent in Europe for the use of its Klotho gene-sequence and gene-delivery systems. \n\n\n  The biopharmaceutical company said the patent would be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases. \n\n\n  ANEW said it licensed this intellectual property on an exclusive worldwide basis from Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Barcelona. \n\n\n  In March, the company received patent approval in China, and is now approved in Hong Kong as well. \n\n\n  ANEW plans to begin product development and expand their intellectual-property portfolios into the Asian markets beginning in 2024. \n\n\n \n\n\n  Write to Chris Wack at chris.wack@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2024 13:39 ET (17:39 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}